Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Sodium feredetate
Kyowa Kirin International UK NewCo Ltd
B03AB03
Sodium feredetate
5.5mg/1ml
Oral solution
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 09010101; GTIN: 5027229000012
PACKAGE LEAFLET: INFORMATION FOR THE USER SYTRON ® 27.5 MG IRON PER 5 ML ORAL SOLUTION Sodium feredetate trihydrate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. – Keep this leaflet. You may need to read it again. – Ask your pharmacist if you need more information or advice. – If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. – You must talk to a doctor if you do not feel better or if you feel worse. WHAT IS IN THIS LEAFLET: 1. What Sytron is and what it is used for 2. What you need to know before you take Sytron 3. How to take Sytron 4. Possible side effects 5. How to store Sytron 6. Contents of the pack and other information 1. WHAT SYTRON IS AND WHAT IT IS USED FOR Sytron is an oral solution for adults, children and babies to treat iron deficiency anaemia caused by too little iron in the body. The form of iron used in this product means that it is less likely to cause stomach upsets than other iron-containing medicines, and will not discolour teeth. It is taken by: • People with iron deficiency anaemia (especially children) • Pregnant women when other forms of oral iron may not be well tolerated • People who have become anaemic as a result of having rheumatoid arthritis. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE SYTRON DO NOT TAKE SYTRON IF YOU: • are ALLERGIC to sodium feredetate trihydrate or any of the other ingredients of this medicine (listed in section 6, please also see end of section 2: ”Sytron contains” for important information about some of the ingredients). • have a history of SENSITIVITY TO IRON -containing preparations. • have a disorder in which there is EXCESSIVE ABSORPTION and STORAGE of IRON such as haemochromatosis or haemosiderosis. • have repeated BLOOD TRANSFUSIONS or have had them in Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Sytron 27.5 mg iron per 5 ml Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml of oral solution contains 207.5 mg of sodium feredetate trihydrate equivalent to 27.5 mg of iron. Excipients with known effect: Each 5 ml of Sytron solution contains: 5 mg of Methyl hydroxybenzoate (E218), 1 mg of Propyl Hydroxybenzoate (E216), 11.4 mg of sodium, 1400 mg of sorbitol, 0.015 ml of ethanol and 0.35 mg of Ponceau 4R (E124) - please refer to section 4.4 for further details. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral solution Clear, red syrup, free of particles 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Sytron is indicated in adults, children and infants for iron deficiency anaemia: • Notably in paediatrics; • In pregnancy when other forms of oral iron may not be well tolerated; In anaemias secondary to rheumatoid arthritis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Treatment: ADULTS AND THE ELDERLY (OVER 65 YEARS): 5ml increasing gradually to 10ml three times daily. PAEDIATRIC POPULATION: Treatment of iron-deficiency anaemia in all paediatric age groups is 3-6 mg/kg (max 200 mg) of elemental iron daily given in 2-3 divided doses. Prophylaxis: BABIES OF LOW BIRTH WEIGHT WHO ARE SOLELY BREAST-FED: A daily dose of 5 mg of elemental iron as prophylactic iron supplementation for babies of low birth weight who are solely breast-fed is recommended. Higher doses up to 2 mg/kg of elemental iron per day might be needed to cover the needs of growing exclusively breastfed infants. Supplementation is started 4-6 weeks after birth and continued until mixed feeding is established. OTHER CHILDREN (ELEMENTAL IRON PER DAY): Age 6 - 24 months: 12.5 mg Age 2 - 5 years: 20-30 mg Age 6 - 11 years: 30 – 60 mg Adolescents: 60 mg Method of administration Oral For instructions on dilution of the medicinal product before administration, see section 6.6. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substa Read the complete document